Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Biome Bank is Australia’s first public stool bank, established to treat debilitating bowel conditions and foster research into gut health.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
Researchers Professor Eric Gowans and Dr Danushka Wijesundara from the Virology team at the Basil Hetzel Institute for Translational Health Research both recently attended national and international conferences thanks to The Hospital Research Foundation (THRF).
Currently undergoing research to develop a HIV vaccine, Prof Gowans was invited to present his results at the annual Australian Society for HIV Medicine.
“The support from THRF enabled me to attend this session and present the work from my laboratory to a group of informed individuals with expertise in HIV vaccine design. This was invaluable as it presented the opportunity for potential collaborations,” Prof Gowans said.
Travelling across the world to America, Dr Wijesundara spoke at two conferences about his DNA vaccines, the first being the 20th Upstate New York Immunology Conference and the Vaccines R&D-2017 Conference in Washington DC.
“Presenting my research on a number of occasions to world-leading researchers in this field was invaluable. I obtained useful feedback from researchers as well as interest in collaborating with our laboratory,” Dr Wijesundara said.
“I am grateful for the opportunity THRF provided me which enabled me to develop academic and industry collaborations that will benefit our research in the laboratory.”
To find out more on how to apply for a Travel Grant, click here.